Surgery – Isolation treatment chambers
Reexamination Certificate
2006-05-02
2006-05-02
Lacyk, John P. (Department: 3735)
Surgery
Isolation treatment chambers
C312S001000
Reexamination Certificate
active
07037254
ABSTRACT:
The present invention relates to devices and methods for providing controlled environments for surgical procedures, as well as transplantation and wound healing. In particular, one embodiment of the present invention provides devices and methods to provide an anaerobic environment for incision sites. In other embodiments, the present invention provides devices and methods to maintain anaerobic conditions during the collection, transport, and implantation of organs, tissues, cells, and other transplant material. In further embodiments, the present invention provides devices and methods for the production and maintenance of an anaerobic environment surrounding sites of trauma or tissue injury. In particular, the present invention provides devices and methods which allow the operator to strictly control the environment for surgical procedures, transplantation and wound healing, etc. Thus, the present invention also finds use in specialized settings where hyperoxic conditions are desireable.
REFERENCES:
patent: 1251258 (1917-12-01), Magill
patent: 1775442 (1930-09-01), Sarason
patent: 2493155 (1950-01-01), McMillan
patent: 3450450 (1969-06-01), Harris et al.
patent: 3874387 (1975-04-01), Barbieri
patent: 4026286 (1977-05-01), Trexler
patent: 4059903 (1977-11-01), Piet et al.
patent: 4089571 (1978-05-01), Landy
patent: 4111753 (1978-09-01), Folsom et al.
patent: 4262091 (1981-04-01), Cox
patent: 4275719 (1981-06-01), Mayer
patent: 4366809 (1983-01-01), Trexler
patent: 4367728 (1983-01-01), Mutke
patent: 4376437 (1983-03-01), Sundheim et al.
patent: 4550713 (1985-11-01), Hyman
patent: 4566293 (1986-01-01), Arner et al.
patent: 4612916 (1986-09-01), Akers et al.
patent: 4701415 (1987-10-01), Dutton et al.
patent: 4903710 (1990-02-01), Jessamine et al.
patent: 4931333 (1990-06-01), Henry
patent: 4950222 (1990-08-01), Scott et al.
patent: 4960143 (1990-10-01), Dore et al.
patent: 5095925 (1992-03-01), Elledge et al.
patent: 5169217 (1992-12-01), Orchard et al.
patent: 5316541 (1994-05-01), Fischer
patent: 5352414 (1994-10-01), Rothenberg
patent: 5380077 (1995-01-01), Puschner et al.
patent: 5636643 (1997-06-01), Argenta et al.
patent: 5727569 (1998-03-01), Benetti et al.
patent: 5730777 (1998-03-01), Petersen et al.
patent: 6184035 (2001-02-01), Csete et al.
patent: 6402724 (2002-06-01), Smith et al.
patent: 0710172 (2000-10-01), None
Barazzone et al., “Oxygen toxicity in mouse lung: pathways to cell death,” Am. J. Respir. Cell Mol. Biol., 19:573-581 [1998].
Cargnoni et al., Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: experimental studies, J. Heart Lung Transplant., 18:478-487 [1999].
Ihnken et al., “Studies of hypoxemic/reoxygenation injury: without aortic clamping,” J. Thorac. Cardiovasc. Surg., 110:1171-1181 [1995].
Ihnken et al., “Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult,” J. Thorac. Cardiovasc. Surg., 116:327-334 [1998].
Knight, “Free radicals: their history and current status in aging and disease,” Ann. Clin. Lab. Sci., 28:331-346 [1998].
Morita et al., “Studies of hypoxemic/reoxygenation injury: without aortic clamping,” J. Thorac. Cardiovasc. Surg., 110:1235-1244 [1995].
Pepper et al., “Sequential oxidative damage, and changes in iron-binding and iron-oxidising plasma antioxidants during cardiopulmonary bypass surgery,” Free Rad. Res., 21:377-385 [1994].
Satoh et al., “Oxygen toxicity induces apoptosis in neuronal cells,” Cell. Mol. Nerurobiol., 18:649-666 [1998].
Sellke et al., “Twenty-four-hour heart preservation using continuous cold perfusion and copper (II) complexes,” J. Surg. Res., 80:171-176 [1998].
Tian et al., “Alterations of antioxidant enzymes and oxidative damage to macromolecules in different organs or rats during aging,” Free Radical Biol. Med., 24:1477-1484 [1998].
Williams et al., “Postoperative lung injury and oxidative damage in patients undergoing pulmonary resection,” Eur. Respir. J., 11:1028-1034 [1998].
Capellier et al., “Oxygen tolerance in patients with acute respiratory failure,” Intensive Care Med 24:422-428 [1998].
Folz et al., “Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia,” J. Clin. Invest. 103:1055-1066 [1999].
Fridovich, “Oxygen toxicity: a radical explantation,” J. Exp. Biol. 201:1203-1209 [1998].
Ihnken et al., “Studies of hypoxemic/reoxygenation injury:without aortic clamping,” J. Thorac. Cardiovasc. Surg., 110:1182-1189 [1995].
Ihnken, “Hyperoxic cardiopulmonary bypass causes reoxygenation injury and lipid peroxidation,” J. Thorac. Cardiovasc. Surg., 114:304-305 [1997].
Oldham and Bowen, “Oxidative stress in critical care: is antioxidant supplementation beneficial?” J. Am. Diet. Assoc. 98:1001-1008 [1998].
Novelli et al., “Vitamin E protects human skeletal muscle from damage during surgical ischemia-reperfusion,” Am. J. Surg. 172:206-209 [1996].
Cox Marion E.
O'Connor Michael
Lacyk John P.
Medlen & Carroll LLP
LandOfFree
Controlled environment device does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled environment device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled environment device will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3653004